Mixed isomers of conjugated linoleic acid (CLA) have been shown to have variable effects on bone formation and resorption in animals. The variable effects of CLA on bone physiology may be due to the different isomers present in common commercial preparations of CLA, and the effects of the predominant individual isomers (9cis,11trans and 10trans,12cis CLA) are not clear. The objective of this study was to determine the effects of individual and mixed isomers of CLA on mineralized bone nodule formation and alkaline phosphatase (ALP) activity in vitro using long-term cultures of SaOS-2 cells. Mineralized bone nodules were stained using the von Kossa method, and ALP activity in cell lysates was measured as a marker of early osteoblast differentiation. The 9cis,11trans isomer increased the number (~4- to 11-fold) and size (~2- to 5-fold) of mineralized bone nodules from 25 to 100 μM, but the 10trans,12cis isomer did not. The increase in mineralized bone nodule formation by 9cis,11trans CLA was accompanied by a variable increase in ALP activity. These results show that the 9cis,11trans isomer of CLA increases the formation of mineralized bone nodules using bone cells of human origin, and provide evidence for isomer-specific effects of CLA on bone health.
Get full access to this article
View all access options for this article.
References
1.
Hanley DA, Josse RG. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 1. Introduction. Can Med Assoc J155: 921–923, 1996.
2.
Heaney RP, Abrams S, Dawson-Hughes B, Looker A, Marcus R, Matkovic V, Weaver C. Peak bone mass. Osteoporos Int11:985–1009, 2000.
3.
Weaver CM. The growing years and prevention of osteoporosis later in life. Proc Nutr Soc59:303–306, 2000.
4.
Weinsier RL, Krumdieck CL. Dairy foods and bone health: examination of the evidence. Am J Clin Nutr72:681–689, 2000.
5.
Watkins BA, Seifert MF. Conjugated linoleic acid and bone biology. J Am Coll Nutr19:478S–486S, 2000.
6.
Watkins BA, Li Y, Lippman HE, Reinwald S, Seifert MF. A test of Ockham’s razor: implications of conjugated linoleic acid in bone biology. Am J Clin Nutr79:1175S–1185S, 2004.
7.
Weiler H, Austin S, Fitzpatrick-Wong S, Nitschmann E, Bankovic-Calic N, Mollard R, Aukema H, Ogborn M. Conjugated linoleic acid reduces parathyroid hormone in health and in polycystic kidney disease in rats. Am J Clin Nutr79:1186S–1189S, 2004.
8.
Watkins BA, Li Y, Romsos DR, Seifert MF. CLA and bone modeling in rats. In: Sebedio J-L, Christie WW, Adlof R, Eds. Advances in Conjugated Linoleic Acid Research. Champaign: AOCS Press, pp218–250, 2003.
9.
Watkins BA, Shen CL, McMurty JP, Xu H, Bain SD, Allen KG, Seifert MF. Dietary lipids modulate bone prostaglandin E2 production, insulin-like growth factor-1 concentration and formation rate in chicks. J Nutr127:1084–1091, 1997.
10.
Cook ME, Jerome DL, Pariza M. Broilers fed conjugated linoleic acid had enhanced bone ash. Poult Sci76:162, 1997.
11.
Park Y, Albright KJ, Liu W, Storkson JM, Cook ME, Pariza MW. Effect of conjugated linoleic acid on body composition in mice. Lipids32:853–858, 1997.
12.
Li Y, Seifert MF, Ney DM, Grahn M, Grant AL, Allen KGD, Watkins BA. Dietary conjugated linoleic acids alter serum IGF-1 and IGF binding protein concentrations and reduce bone formation in rats fed (n-6) or (n-3) fatty acids. J Bone Miner Res14:1153–1162, 1999.
13.
Kelly O, Cusack S, Jewell C, Cashman KD. The effect of polyunsaturated fatty acids, including conjugated linoleic acid, on calcium absorption and bone metabolism and composition in young growing rats. Br J Nutr90:743–750, 2003.
14.
Kelly O, Cashman KD. The effect of conjugated linoleic acid on calcium absorption and bone metabolism and composition in adult ovariectomised rats. Prostaglandins Leukot Essent Fatty Acids71:295–301, 2004.
15.
Kepler CR, Hirons KP, McNeill JJ, Tove SB. Intermediates and products of biohydrogenation of linoleic acid by Butyrivibrio fibrisolvens.J Biol Chem241:1350–1354, 1966.
16.
Chin SF, Liu W, Storkson JM, Ha YL, Pariza MW. Dietary sources of conjugated dienoic isomers of linoleic acid, a newly recognized class of anticarcinogens. J Food Comp Anal5:185–197, 1992.
17.
Ha YL, Grimm NK, Pariza MW. Newly recognized anticarcinogenic fatty acids: Identification and quantification in natural and processed cheeses. J Agri Food Chem37:75–81, 1989.
18.
Ma DW, Wierzbicki AA, Field CJ, Clandinin MT. Conjugated linoleic acid in Canadian dairy and beef products. J Agri Food Chem47:1956–1960, 1999.
19.
Pariza MW, Park Y, Cook ME. Mechanisms of action of conjugated linoleic acid: evidence and speculation. Proc Soc Exp Biol Med223:8–13, 2000.
20.
Ip C, Scimeca JA, Thompson HJ. Conjugated linoleic acid. A powerful anticarcinogen from animal fat sources. Cancer74:1050–1054, 1994.
21.
Lee KN, Kritchevsky D, Pariza MW. Conjugated linoleic acid and atherosclerosis in rabbits. Atherosclerosis108:19–25, 1994.
22.
Houseknecht KL, Vanden Heuvel JP, Moya-Camarena SY, Portocarrero CP, Peck LW, Nickel KP, Belury MA. Dietary conjugated linoleic acid normalizes impaired glucose tolerance in the Zucker diabetic fatty fa/fa rat. Biochem Biophys Res Commun244:678–682, 1998.
23.
MacDonald HB. Conjugated linoleic acid and disease prevention: a review of current knowledge. J Am Coll Nutr19:111S–118S, 2000.
24.
Belury MA. Dietary conjugated linoleic acid in health: physiological effects and mechanisms of action. Annu Rev Nutr22:505–531, 2002.
25.
Ostrowska E, Suster D, Muralitharan M, Cross RF, Leury BJ, Bauman DE, Dunshea FR. Conjugated linoleic acid decreases fat accretion in pigs: evaluation by dual-energy X-ray absorptiometry. Br J Nutr89: 219–229, 2003.
26.
Watkins BA, Li Y, Lippman HE, Feng S. Modulatory effect of omega-3 polyunsaturated fatty acids on osteoblast function and bone metabolism. Prostaglandins Leukot Essent Fatty Acids68:387–398, 2003.
27.
Brownbill RA, Petrosian M, Ilich JZ. Association between dietary conjugated linoleic acid and bone mineral density in postmenopausal women. J Am Coll Nutr24:177–181, 2005.
28.
Doyle L, Jewell C, Mullen A, Nugent AP, Roche HM, Cashman KD. Effect of dietary supplementation with conjugated linoleic acid on markers of calcium and bone metabolism in healthy adult men. European Journal of Clinical Nutrition2005:432–440, 2005.
29.
Kreider RB, Ferreira MP, Greenwood M, Wilson M, Almada AL. Effects of conjugated linoleic acid supplementation during resistance training on body composition, bone density, strength, and selected hematological markers. J Strength Cond Res16:325–334, 2002.
30.
Cusack S, Jewell C, Cashman KD. The effect of conjugated linoleic acid on the viability and metabolism of human osteoblast-like cells. Prostaglandins Leukot Essent Fatty Acids72:29–39, 2005.
31.
Park Y, Storkson JM, Albright KJ, Liu W, Pariza MW. Evidence that the trans-10,cis-12 isomer of conjugated linoleic acid induces body composition changes in mice. Lipids34:235–241, 1999.
32.
Park Y, Albright KJ, Storkson JM, Liu W, Cook ME, Pariza MW. Changes in body composition in mice during feeding and withdrawal of conjugated linoleic acid. Lipids34:243–248, 1999.
33.
Aubin JE. Advances in the osteoblast lineage. Biochem Cell Biol76: 899–910, 1998.
34.
Lian BJ, Stein GS, Canalis E, Gehron Robey P, Boskey AL. Bone formation: osteoblast lineage cells, growth factors, matrix proteins and the mineralization process. In: Favus MJ, Ed. Primer on the Metabolic Bone Disease and Disorder of Mineral Metabolism. Philadelphia: Lippincott Williams & Williams, pp14–38, 1999.
35.
Rao LG, Liu LJ, Murray TM, McDermott E. 17Beta-estradiol stimulates mineralized bone nodule formation when added intermittently to SaOS-2 cells. Drug Metabol Drug Interact18:149–158, 2001.
36.
Rao LG, Wylie JN, Sutherland MS, Murray TM. 17 beta-estradiol and parathyroid hormone potentiate each other’s stimulatory effects on alkaline phosphatase activity in SaOS-2 cells in a differentiation-dependent manner. Endocrinology134:614–620, 1994.
37.
Rao LG, Sutherland MK, Reddy GS, Siu-Caldera ML, Uskokovic MR, Murray TM. Effects of 1alpha,25-dihydroxy-16ene, 23yne-vitamin D3 on osteoblastic function in human osteosarcoma SaOS-2 cells: differentiation-stage dependence and modulation by 17-beta estradiol. Bone19:621–627, 1996.
38.
Lowry O. Micromethods for the assay of enzyme, II. Specific procedures. Alkaline phosphatase. Methods Enzymol4:371–372, 1955.
39.
Liu W, Toyosawa S, Furuichi T, Kanatani N, Yoshida C, Liu Y, Himeno M, Narai S, Yamaguchi A, Komori T. Overexpression of Cbfa1 in osteoblasts inhibits osteoblast maturation and causes osteopenia with multiple fractures. J Cell Biol155:157–166, 2001.
40.
Li Y, Watkins BA. Conjugated linoleic acids alter bone fatty acid composition and reduce ex vivo prostaglandin E2 biosynthesis in rats fed n-6 or n-3 fatty acids. Lipids33:417–425, 1998.
41.
Takiguchi T, Kobayashi M, Nagashima C, Yamaguchi A, Nishihara T, Hasegawa K. Effect of prostaglandin E2 on recombinant human bone morphogenetic protein-2-stimulated osteoblastic differentiation in human periodontal ligament cells. J Periodontal Res34:431–436, 1999.
42.
Quinn JMW, Sabokbar A, Denne M, de Vernejoul M-C, McGee JOD, Athanason NA. Inhibitory and stimulatory effects of prostaglandins on osteoclast differentiation. Calcified Tissue International60:63–70, 1996.
43.
Mundy G, Garrett R, Harris S, Chan J, Chen D, Rossini G, Boyce B, Zhao M, Gutierrez G. Stimulation of bone formation in vitro and in rodents by statins. Science286:1946–1949, 1999.
